From the Journals

A Smart Speaker for Diabetes Care?

Randomized trial links a voice-based virtual assistant to reduced distress and modest HbA1c improvements in older adults with type 2 diabetes

Share

The IVAM-ED randomized clinical trial explored the efficacy of a voice-activated virtual assistant in reducing mental distress and improving glycemic control among older adults with type 2 diabetes. Conducted from June 2023 to February 2024 in Brazil, the study involved 112 participants aged 65 and older who utilized a smart speaker program for 12 weeks. Results indicated positive outcomes in mental distress scores, quality of life, diabetes self-care, and HbA1c levels compared to standard care, highlighting potential benefits of digital health interventions.

Original Source(s)

A Smart Speaker for Diabetes Care?

Randomized trial links a voice-based virtual assistant to reduced distress and modest HbA1c improvements in older adults with type 2 diabetes

  • by Jess Allerton

  • March 2, 2026

  • 2 min

Related Content

AI and Diabetes: Promise and Precaution

The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

Retrospective study finds machine-learning model identifies clinical factors associated with preterm delivery in a high-risk obstetric population.

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.